Interventional Cardiology Resource Center Editorial Programs

 
 
  • The Physician's Role in Patient Decision-Making   Dr Moat leads a panel discussion on the delicate art of helping patients make treatment decisions when there is some uncertainty about the best strategy.
  • Mandrola's Top 10 Cardiology Stories 2015 In what is becoming an annual tradition, Dr John Mandrola reviews his top 10 stories of 2015 in the field of cardiovascular medicine.
  • CMS Proposal on Watchman Is the Right Decision The Watchman left atrial appendage closure device had a rocky road to FDA approval, but a CMS proposal could place new limitations on its use, which would be a good thing, according to Dr John Mandrola.
  • The Cardiology Show From AHA 2015 With Dr Valentin Fuster   The SPRINT hypertension trial tops a show that also covers in-ambulance troponin testing, repair vs replace for ischemic mitral regurgitation, peer counseling to reduce CV risk factors, and four runners-up trials.
  • AHA Ticagrelor and Science: Is the Dyspnea Really Worth It? Dr Melissa Walton-Shirley reports on the presentation about the long-term tolerability of ticagrelor in PEGASUS vs the results of her experience with the drug.
  • AHA AHA 2015 Scientific Sessions Previewed by John Mandrola Dr John Mandrola peruses the program for the upcoming American Heart Association Scientific Sessions in Orlando and outlines the studies he'll be looking out for.
  • FFR-CT Angiography: The PROMISE of PLATFORM   Dr Harrington interviews Dr Douglas about the PLATFORM trial on FFR-CT angiography and the use of noninvasive functional testing to reduce inappropriate cardiac catheterizations.
  • A Low-Tech Approach to AKI Prevention A new study shows how the blood pressure cuff may assist in providing robust protection against bypass surgery-related ischemic AKI.
  • ESC Interventional Cardiology Highlights   Drs Fox and Stone review late-breaking data on bioresorbable stents, FFRCT, and bivalirudin from the European Society of Cardiology Congress.
  • LEADLESS II: Dr Vivek Reddy Interviewed   From ESC, Dr Mandrola interviews Dr Reddy about the single-chamber leadless pacemaker that doesn't require a subcutaneous pocket.
  • The Cardiology Show From ESC 2015 with Dr Valentin Fuster   UPDATED with Transcript // The panel discuss a leadless pacemaker, cyclosporine and reperfusion injury, hypertension treatments, high-sensitivity troponin for early MI diagnosis, and yet more data on antithrombins for PCI.
  • ESC One-Liners From ESC 2015 Day 1 Dr Melissa Walton-Shirley zips through the take-home messages of 23 presentations.
  • ESC TAVI: A Solution for All Patients: A Pro-Con Debate at ESC 2015 Dr John Mandrola reports on a debate centered on who should undergo TAVI vs surgical aortic-valve replacement as well as one on whether very high-risk patients should receive the procedure.
  • Seeing Every Patient Encounter as a Research Opportunity   Dr Harrington interviews HEAT-PPCI principal investigator Dr Rod Stables about engaging the hospital community in research and the benefits for all concerned.
  • Bioresorbable Stents: The Next Big Thing? Over 100,000 patients worldwide have had a bioresorbable vascular scaffold implanted. What should US cardiologists expect if these devices come stateside?
  • TAVR vs SAVR Across the Risk Spectrum   Mayo experts on the choice of transcatheter vs surgical aortic valves replacement in patients at different levels of risk and why the heart team is still needed.
  • Rethinking the Cath-Lab Reflex in Patients With ACS Dr John Mandrola suggests that the 10-year results from RITA-3 should make cardiologists stop to think before rushing a patient to the cath lab and revascularization procedures.
  • PCI Without Surgery On Site: Let Them Eat Cake Dr Melissa Walton-Shirley offers a sad reminiscence about a patient with MI who failed lytic therapy and, because of bad weather and state restrictions at that time, had no other options.
  • Inappropriate Cath, Appropriate Revascularization   Two cases prompt Dr Bilazarian to suggest a new category for the appropriate use criteria for coronary revascularization.
  • TOTAL Breakdown: Thrombus Aspiration Subgroup Analyses   Manual thrombectomy was not associated with benefit in the TOTAL trial and appeared to increase stroke rates. Drs Byrne and Jolly provide insight from subgroup analyses presented at EuroPCR.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.